Philip Morris International CEO: We have no plans of getting into cannabis thumbnail

Philip Morris International CEO: We have no plans of getting into cannabis

Philip Morris International CEO Andre’ Calantzopoulos discusses why his company is keeping clear of the cannabis industry. The Philip Morris International CEO also discusses the company’s push to create a…

Edibles the key growth opportunity in cannabis sector? thumbnail

Edibles the key growth opportunity in cannabis sector?

Cresco Labs CEO Charlie Bachtell on the company’s IPO and the outlook for the cannabis sector.

How can investors gain from cannabis market? thumbnail

How can investors gain from cannabis market?

Canndescent CEO Adrian Sedlin on the opportunities for investors in cannabis.

Can average investors' portfolios benefit from cannabis stocks? thumbnail

Can average investors’ portfolios benefit from cannabis stocks?

Richardson GMP Portfolio Manager Chris Kerlow on the potential investment opportunities in cannabis.

Cannabis dispensary MedMen aims to mainstream marijuana thumbnail

Cannabis dispensary MedMen aims to mainstream marijuana

MedMen CEO and Co-Founder Adam Bierman discusses the industry’s greatest hurdles and why mainstreaming marijuana is the mission behind the cannabis dispensary company.

Rep. Gaetz introduces legislation that would expand research into medical cannabis thumbnail

Rep. Gaetz introduces legislation that would expand research into medical cannabis

Rep. Matt Gaetz (R-Fla.) introduced the Medical Cannabis Research Act and discusses how it aims to research cures offered by medical cannabis.

Capital markets are open in Canada for cannabis: Greg Taylor thumbnail

Capital markets are open in Canada for cannabis: Greg Taylor

Purpose Investments Portfolio Manager Greg Taylor on the legalization of recreational marijuana in Canada and the opportunities for investors in cannabis-related industries.

The big money flowing into the cannabis industry thumbnail

The big money flowing into the cannabis industry

Canndescent CEO Adrian Sedlin on the company’s efforts to raise $100 million and the outlook for the cannabis sector.